The Elongin BC complex and the von Hippel–Lindau tumor suppressor protein
- 17 April 1998
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1377 (2) , M49-M54
- https://doi.org/10.1016/s0304-419x(97)00035-8
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Binding of the von Hippel-Lindau Tumor Suppressor Protein to Elongin B and CScience, 1995
- Elongin (SIII): A Multisubunit Regulator of Elongation by RNA Polymerase IIScience, 1995
- Inhibition of Transcription Elongation by the VHL Tumor Suppressor ProteinScience, 1995
- Positive regulation of general transcription factor SIII by a tailed ubiquitin homolog.Proceedings of the National Academy of Sciences, 1995
- Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotypeHuman Mutation, 1995
- Somatic mutations of the von Hippel — Lindau disease tumour suppressor gene in non-familial clear cell renal carcinomaHuman Molecular Genetics, 1994
- Molecular cloning of an essential subunit of RNA polymerase II elongation factor SIII.Proceedings of the National Academy of Sciences, 1994
- Mutations of the VHL tumour suppressor gene in renal carcinomaNature Genetics, 1994
- Identification of the von Hippel-Lindau Disease Tumor Suppressor GeneScience, 1993
- Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.Journal of Clinical Investigation, 1993